|
2025
|
Invention
|
Adenoviral vectors encoding hepatitis b viral antigens fused to herpes virus glycoprotein d and m... |
|
|
Invention
|
Acetyl-coa synthetase 2 (acss2) inhibitors and methods using same.
The present disclosure provid... |
|
|
Invention
|
Filovirus consensus antigens, nucleic acid constructs and vaccines made therefrom, and methods of... |
|
|
Invention
|
Variant survivin vaccine for treatment of cancer.
The invention concerns a variant (double mutan... |
|
2024
|
Invention
|
Use of lactoferrin for generating myeloid-derived suppressor cells.
Provided herein are methods ... |
|
|
Invention
|
Vaccines against coronavirus and methods of use.
Disclosed herein are nucleic acid molecules enc... |
|
|
Invention
|
Identifying microbial gene expression in human tissues.
The present invention relates to a tool ... |
|
|
Invention
|
Lipid nanoparticles and methods of use for dna delivery. The present disclosure relates to lipids... |
|
|
Invention
|
Rolling circle amplified dna encoded antigens and methods of use thereof. Disclosed herein are ro... |
|
|
Invention
|
Compostions and methods for diagnosing lung cancers using gene expression profiles.
Methods and ... |
|
|
Invention
|
Dna encoded nanoparticles with cytokine adjuvant and method of use thereof. Disclosed herein are ... |
|
|
Invention
|
Systems of single-cell labeling and methods of using the same.
The disclosure provides materials... |
|
|
Invention
|
Metabolic immunomodulators that potentiate anti-tumor immunity in cancer. Described herein are me... |
|
|
Invention
|
Modified h3 hemagglutinin antigens and methods of use thereof. Disclosed herein are immune focuse... |
|
|
Invention
|
Optimized nucleic acid antibody constructs.
Disclosed herein are compositions comprising structu... |
|
|
Invention
|
Non-neutralizing aav constructs and methods of generating and using same. Provided are engineered... |
|
|
Invention
|
Methods of treating cancers overexpressing carm1 with ezh2 inhibitors and a parp inhibitor.
Ther... |
|
|
Invention
|
Vaccines against african swine fever virus, and methods of using same. An aspect of the present i... |
|
|
Invention
|
Dna antibody constructs for use against middle east respiratory syndrome coronavirus.
Disclosed ... |
|
|
Invention
|
Structure-based optimization of s6k2 inhibitor cd02 to target melanoma. Disclosed herein are comp... |
|
|
Invention
|
Compositions comprising aptamers and methods of modulating the immune response using the same. Th... |
|
|
Invention
|
Combination therapies targeting mitochondria for cancer therapy.
Pharmaceutical compositions for... |
|
|
Invention
|
Adar1 inhibitors and uses thereof. Provided herein are ADAR1 inhibitors and methods of treating c... |
|
|
Invention
|
Methods and compositions for diagnosis of ectopic pregnancy. Methods and compositions are provide... |
|
|
Invention
|
Methods and compositions for diagnosis of ectopic pregnancy, intrauterine pregnancy, and spontane... |
|
|
Invention
|
Tri-specific t-cell engagers and methods of use in cancer therapeutics. The invention provides co... |
|
|
Invention
|
Glycan modified sars-cov-2 glycoprotein nanoparticles and methods of use thereof. Disclosed herei... |
|
|
Invention
|
Mage-a vaccines and methods of treatment using the same.
Disclosed herein are compositions and m... |
|
|
Invention
|
Nanoparticle compositions and uses thereof for reactivation of latent hiv. Provided herein are na... |
|
|
Invention
|
Epitope editing and multi-specific immunce-cell engager therapy and methods of use. Disclosed her... |
|
|
Invention
|
Antibody-cytokine chimeras. Disclosed herein are antibody cytokine chimeras, nucleic acid molecul... |
|
|
Invention
|
Methods of rescuing stop codons via genetic reassignment with ace-trna.
The present invention pr... |
|
|
Invention
|
Glycoprotein d variants as vaccine adjuvants.
Disclosed herein are compositions for increasing t... |
|
2023
|
Invention
|
Delivery system to target gram-negative bacteria.
Disclosed herein are compounds of the formulas... |
|
|
Invention
|
Stabilized spike protein and method of use thereof as a coronavirus disease 2019 (covid-19) vacci... |
|
|
Invention
|
Bispecific t cell engagers targeting tumor antigens.
The present invention provides bispecific b... |
|
|
Invention
|
Compositions and methods for the treatment of cancer and other proliferative diseases.
The prese... |
|
|
Invention
|
Modified primary immune cells for induction or enhancement of immunotherapy.
Provided herein are... |
|
|
Invention
|
Novel and highly selective sars-cov-2 mpro inhibitors.
Disclosed herein are compounds of the for... |
|
|
Invention
|
Pan-coronavirus immunogenic compositions.
The present invention generally relates to immunogenic... |
|
|
Invention
|
Isocitrate dehydrogenase 1 inhibitors and methods of use thereof.
The present disclosure provide... |
|
2022
|
Invention
|
Bispecific immune cell engagers targeting hiv and methods of use thereof.
Disclosed herein are c... |
|
|
Invention
|
Dna encoded antibodies with fc modifications.
Disclosed herein are nucleic acid encoded Fc-modif... |
|
|
Invention
|
Antibodies for use against sars-cov-2.
Disclosed herein are antibodies to SARS-COV-2 antigens an... |
|
|
Invention
|
Novel immune cell engagers for immunotherapy.
The present invention provides natural killer enga... |
|
|
Invention
|
Bispecific t-cell engagers targeting fshr and methods of use in cancer theraputics.
Disclosed he... |
|
|
Invention
|
Novel epstein barr virus immunotherapies.
The present invention generally relates to immunogenic... |
|
|
Invention
|
Methods for identifying adar1 inhibitors, and compositions and methods of use in treating cancer.... |
|
|
Invention
|
Synthetic dna vaccine immunogenic improvements.
Disclosed herein is a composition comprising one... |
|
|
Invention
|
Dna antibody constructs for use against plasmodium parasites.
Disclosed herein is a composition ... |
